PATENT CLAIM ANALYSIS

Application Number: 16069092
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["424", "450000"]

Abstract:
Novel compounds inhibiting ATR protein kinase include compounds of formula (I) disclosed herein, as well as liposome formulations comprising ATR protein kinase inhibitor compounds. The compositions are useful for the treatment of cancer.

Claim (Index 2):
A compound of the formula of Compound 5, or a pharmaceutically acceptable salt thereof:

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.26667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15337274', '15852551', '15027997', '15241128', '13662135']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6294784535906345
- 35 USC 102 Novelty (BERT): 0.517840886115271
- Combined Prediction Score: 0.6183146968430981
- Mean Citation Score: 255.986702
- Max Citation Score: 285.9236
- Similarity Product: 216.25173102257253

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test